• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-羟色胺受体在西伯利亚仓鼠食物摄入调节中的作用。

Involvement of 5-HT receptors in the regulation of food intake in Siberian hamsters.

作者信息

Schuhler S, Clark A, Joseph W, Patel A, Lehnen K, Stratford E, Horan T L, Fone K C F, Ebling F J P

机构信息

School of Biomedical Sciences, University of Nottingham, Nottingham, UK.

出版信息

J Neuroendocrinol. 2005 May;17(5):276-85. doi: 10.1111/j.1365-2826.2005.01303.x.

DOI:10.1111/j.1365-2826.2005.01303.x
PMID:15869562
Abstract

The Siberian hamster provides a physiological model for understanding the hypothalamic control of energy metabolism as it undergoes annual photoperiod-regulated cycles of body weight (i.e. fattening in summer, and catabolism of fat stores in winter). As a first step to investigate whether enhanced serotonergic (5-HT) tone might underlie the catabolic processes in short days, we investigated whether serotonergic stimulation can produce catabolic actions in fat hamsters housed in long days. Acute treatment with the serotonin reuptake inhibitor (+/-) fenfluramine (8 mg/kg, i.p.) produced a prolonged, dose-dependent reduction in food intake in both photoperiods. Behavioural observations and radiotelemetry analyses revealed that this anorectic effect of fenfluramine was associated with short-term increases in locomotor activity and in core body temperature. In a subsequent series of studies, hamsters were pretreated with the 5-HT2C receptor antagonist SB242084 (4 mg/kg, i.p.). This 5-HT2C receptor antagonist completely blocked the anorectic actions of fenfluramine, but did not decrease the hyperthermia or hyperlocomotion induced by fenfluramine; thus, the anorectic actions of fenfluramine probably reflect actions via the 5-HT2C receptor. Consistent with these observations, treatment of hamsters with the 5-HT2C receptor agonist VER 3323 (10 mg/kg, i.p.) or the 5-HT1B/2C receptor agonist mCPP (3 mg/kg, i.p.) reduced food intake. The response to manipulation of serotonergic pathways was not affected by the ambient photoperiod in any of these studies. We conclude that the anorectic actions of fenfluramine are not an indirect consequence of serotonergic actions on arousal pathways, and that its actions on feeding in the Siberian hamster are most likely to be mediated by the 5-HT2C receptor.

摘要

西伯利亚仓鼠提供了一个生理模型,用于理解下丘脑对能量代谢的控制,因为它会经历由光周期调节的年度体重循环(即夏季增肥,冬季脂肪储备分解代谢)。作为研究增强的血清素能(5-羟色胺,5-HT)张力是否可能是短日照下分解代谢过程基础的第一步,我们研究了血清素能刺激是否能在长日照饲养的肥胖仓鼠中产生分解代谢作用。用血清素再摄取抑制剂(±)芬氟拉明(8毫克/千克,腹腔注射)进行急性处理,在两个光周期中均导致食物摄入量出现长时间的、剂量依赖性减少。行为观察和无线电遥测分析表明,芬氟拉明的这种厌食作用与运动活动和核心体温的短期升高有关。在随后的一系列研究中,仓鼠先用5-HT2C受体拮抗剂SB242084(4毫克/千克,腹腔注射)进行预处理。这种5-HT2C受体拮抗剂完全阻断了芬氟拉明的厌食作用,但并未降低芬氟拉明诱导的体温过高或运动亢进;因此,芬氟拉明的厌食作用可能反映了通过5-HT2C受体的作用。与这些观察结果一致,用5-HT2C受体激动剂VER 3323(10毫克/千克,腹腔注射)或5-HT1B/2C受体激动剂mCPP(3毫克/千克,腹腔注射)处理仓鼠会减少食物摄入量。在任何这些研究中,对血清素能途径操纵的反应均不受环境光周期的影响。我们得出结论,芬氟拉明的厌食作用不是血清素能对觉醒途径作用的间接后果,并且其对西伯利亚仓鼠进食的作用最有可能由5-HT2C受体介导。

相似文献

1
Involvement of 5-HT receptors in the regulation of food intake in Siberian hamsters.5-羟色胺受体在西伯利亚仓鼠食物摄入调节中的作用。
J Neuroendocrinol. 2005 May;17(5):276-85. doi: 10.1111/j.1365-2826.2005.01303.x.
2
Thyrotrophin-releasing hormone decreases feeding and increases body temperature, activity and oxygen consumption in Siberian hamsters.促甲状腺激素释放激素可减少西伯利亚仓鼠的进食量,并提高其体温、活动量和耗氧量。
J Neuroendocrinol. 2007 Apr;19(4):239-49. doi: 10.1111/j.1365-2826.2006.01524.x.
3
Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist and d-fenfluramine on feeding patterns in the rat.5-羟色胺2C受体激动剂Ro 60-0175与右旋芬氟拉明对大鼠进食模式作用的相似性。
Psychopharmacology (Berl). 2000 Oct;152(3):256-67. doi: 10.1007/s002130000504.
4
Milnacipran, a serotonin and norepinephrine reuptake inhibitor, induces appetite-suppressing effects without inducing hypothalamic stress responses in mice.米那普明是一种5-羟色胺和去甲肾上腺素再摄取抑制剂,可在不诱发小鼠下丘脑应激反应的情况下产生食欲抑制作用。
Am J Physiol Regul Integr Comp Physiol. 2007 May;292(5):R1775-81. doi: 10.1152/ajpregu.00527.2006. Epub 2007 Jan 11.
5
Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors.右旋芬氟拉明和去甲右旋芬氟拉明在大鼠中诱导的摄食减少是由5-羟色胺2C受体介导的证据。
Neuropharmacology. 2001 Aug;41(2):200-9. doi: 10.1016/s0028-3908(01)00063-6.
6
Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats.持续输注mCPP、Ro 60-0175和d-芬氟拉明对大鼠食物摄入量、饮水量、体重和运动活动的比较影响。
Br J Pharmacol. 2000 Jul;130(6):1305-14. doi: 10.1038/sj.bjp.0703443.
7
VGF-derived peptide, TLQP-21, regulates food intake and body weight in Siberian hamsters.VGF衍生肽TLQP-21调节西伯利亚仓鼠的食物摄入量和体重。
Endocrinology. 2007 Aug;148(8):4044-55. doi: 10.1210/en.2007-0038. Epub 2007 Apr 26.
8
The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists.5-羟色胺(2C)受体拮抗剂SB242084对由选择性或混合性间接5-羟色胺能和多巴胺能激动剂诱导的运动活性的影响。
Psychopharmacology (Berl). 2006 Sep;187(4):515-25. doi: 10.1007/s00213-006-0453-9. Epub 2006 Jul 11.
9
Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors.血清素5-HT2C受体激动剂通过下游激活黑皮质素4受体促进食欲减退。
Endocrinology. 2008 Mar;149(3):1323-8. doi: 10.1210/en.2007-1321. Epub 2007 Nov 26.
10
Effects of food deprivation and metabolic fuel utilization on the photoperiodic control of food intake in Siberian hamsters.食物剥夺和代谢燃料利用对西伯利亚仓鼠食物摄入光周期控制的影响。
Physiol Behav. 1995 Jan;57(1):61-8. doi: 10.1016/0031-9384(94)00203-h.

引用本文的文献

1
5-HT Receptor Stimulation in Obesity Treatment: Orthosteric Agonists vs. Allosteric Modulators.5-羟色胺受体刺激在肥胖治疗中的应用:正构激动剂与变构调节剂。
Nutrients. 2023 Mar 17;15(6):1449. doi: 10.3390/nu15061449.
2
Serotonin, food intake, and obesity.血清素、食物摄入与肥胖。
Obes Rev. 2021 Jul;22(7):e13210. doi: 10.1111/obr.13210. Epub 2021 Feb 9.
3
Pharmacological targeting of the serotonergic system for the treatment of obesity.针对血清素能系统进行药物靶向治疗肥胖症。
J Physiol. 2009 Jan 15;587(1):49-60. doi: 10.1113/jphysiol.2008.164152. Epub 2008 Nov 24.